Literature DB >> 9544515

Permutational distribution of the log-rank statistic under random censorship with applications to carcinogenicity assays.

G Heimann1, G Neuhaus.   

Abstract

In the random censorship model, the log-rank test is often used for comparing a control group with different dose groups. If the number of tumors is small, so-called exact methods are often applied for computing critical values from a permutational distribution. Two of these exact methods are discussed and shown to be incorrect. The correct permutational distribution is derived and studied with respect to its behavior under unequal censoring in the light of recent results proving that the permutational version and the unconditional version of the log-rank test are asymptotically equivalent even under unequal censoring. The log-rank test is studied by simulations of a realistic scenario from a bioassay with small numbers of tumors.

Entities:  

Mesh:

Year:  1998        PMID: 9544515

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  5 in total

1.  Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.

Authors:  Rui Wang; Stephen W Lagakos; Robert J Gray
Journal:  Biostatistics       Date:  2010-05-02       Impact factor: 5.899

2.  Weighted logrank tests for interval censored data when assessment times depend on treatment.

Authors:  Michael P Fay; Joanna H Shih
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

3.  A versatile test for equality of two survival functions based on weighted differences of Kaplan-Meier curves.

Authors:  Hajime Uno; Lu Tian; Brian Claggett; L J Wei
Journal:  Stat Med       Date:  2015-07-20       Impact factor: 2.373

4.  Accurate computation of survival statistics in genome-wide studies.

Authors:  Fabio Vandin; Alexandra Papoutsaki; Benjamin J Raphael; Eli Upfal
Journal:  PLoS Comput Biol       Date:  2015-05-07       Impact factor: 4.475

5.  High-risk HPV type-specific clearance rates in cervical screening.

Authors:  N W J Bulkmans; J Berkhof; S Bulk; M C G Bleeker; F J van Kemenade; L Rozendaal; P J F Snijders; C J L M Meijer
Journal:  Br J Cancer       Date:  2007-03-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.